Predicted to enable NAD+ synthase (glutamine-hydrolyzing) activity and glutaminase activity. Predicted to be involved in 'de novo' NAD biosynthetic process. Predicted to be active in cytoplasm. Human ortholog(s) of this gene implicated in high grade glioma. Orthologous to human NADSYN1 (NAD synthetase 1). [provided by Alliance of Genome Resources, Apr 2022]